TURKISH JOURNAL OF NEUROLOGY, vol.15, no.2, pp.64-70, 2009 (ESCI)
Objective: To report the clinical follow-up, side effects, and magnetic resonance imaging (MRI) findings of mitoxantrone treatment in patients in the early phase of secondary progressive and exacerbating relapsing-remitting multiple sclerosis.